Shihyoung Kim
Overview
Explore the profile of Shihyoung Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baek A, Lee G, Golconda S, Rayhan A, Manganaris A, Chen S, et al.
Nat Microbiol
. 2024 Apr;
9(5):1340-1355.
PMID: 38605174
Although the significance of chemical modifications on RNA is acknowledged, the evolutionary benefits and specific roles in human immunodeficiency virus (HIV-1) replication remain elusive. Most studies have provided only population-averaged...
2.
Baek A, Rayhan A, Lee G, Golconda S, Yu H, Kim S, et al.
Methods Protoc
. 2024 Jan;
7(1).
PMID: 38251200
The biological significance of chemical modifications to the ribonucleic acid (RNA) of human immunodeficiency virus type-1 (HIV-1) has been recognized. However, our understanding of the site-specific and context-dependent roles of...
3.
Wang L, Suryawanshi G, Kim S, Guan X, Bonifacino A, Metzger M, et al.
Heliyon
. 2023 Oct;
9(9):e19435.
PMID: 37810095
Selective T-cell depletion prior to cell or organ transplantation is considered a preconditioning regimen to induce tolerance and immunosuppression. An immunotoxin consisting of a recombinant anti-CD3 antibody conjugated with diphtheria...
4.
Kim S, Shukla R, Yu H, Baek A, Cressman S, Golconda S, et al.
Front Immunol
. 2022 Nov;
13:1011190.
PMID: 36389741
CD3-epsilon(CD3e) immunotoxins (IT), a promising precision reagent for various clinical conditions requiring effective depletion of T cells, often shows limited treatment efficacy for largely unknown reasons. Tissue-resident T cells that...
5.
Kim S, Shukla R, Kim E, Cressman S, Yu H, Baek A, et al.
Biomedicines
. 2022 Jun;
10(6).
PMID: 35740248
Anti-CD3-epsilon (CD3e) monoclonal antibodies (mAbs) and CD3e immunotoxins (ITs) are promising targeted therapy options for various T-cell disorders. Despite significant advances in mAb and IT engineering, vascular leakage syndrome (VLS)...
6.
Suryawanshi G, Khamaikawin W, Wen J, Shimizu S, Arokium H, Xie Y, et al.
Sci Adv
. 2020 Aug;
6(30):eaay9206.
PMID: 32766447
Despite advances in hematopoietic stem/progenitor cell (HSPC) transplant for HIV-1-infected patients, the impact of a preexisting HIV-1 infection on the engraftment and clonal repopulation of HSPCs remains poorly understood. We...